Embl Technology Fund Ii Gmbh & Co. Kg - Net Worth and Insider Trading
Embl Technology Fund Ii Gmbh & Co. Kg Net Worth
The estimated net worth of Embl Technology Fund Ii Gmbh & Co. Kg is at least $219,346 dollars as of 2024-11-13. Embl Technology Fund Ii Gmbh & Co. Kg is the 10% Owner of X4 Pharmaceuticals Inc and owns about 370,454 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $219,346. Details can be seen in Embl Technology Fund Ii Gmbh & Co. Kg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Embl Technology Fund Ii Gmbh & Co. Kg has not made any transactions after 2017-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Embl Technology Fund Ii Gmbh & Co. Kg
Embl Technology Fund Ii Gmbh & Co. Kg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Embl Technology Fund Ii Gmbh & Co. Kg owns 1 companies in total, including X4 Pharmaceuticals Inc (XFOR) .
Insider Ownership Summary of Embl Technology Fund Ii Gmbh & Co. Kg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 10 percent owner |
Embl Technology Fund Ii Gmbh & Co. Kg Latest Holdings Summary
Embl Technology Fund Ii Gmbh & Co. Kg currently owns a total of 1 stock. Embl Technology Fund Ii Gmbh & Co. Kg owns 370,454 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $219,346.
Latest Holdings of Embl Technology Fund Ii Gmbh & Co. Kg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 370,454 | 0.59 | 219,346 |
Holding Weightings of Embl Technology Fund Ii Gmbh & Co. Kg
Embl Technology Fund Ii Gmbh & Co. Kg Form 4 Trading Tracker
According to the SEC Form 4 filings, Embl Technology Fund Ii Gmbh & Co. Kg has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 20,000 shares on November 20, 2017, which cost Embl Technology Fund Ii Gmbh & Co. Kg around $200,000.
Insider Trading History of Embl Technology Fund Ii Gmbh & Co. Kg
- 1
Embl Technology Fund Ii Gmbh & Co. Kg Trading Performance
GuruFocus tracks the stock performance after each of Embl Technology Fund Ii Gmbh & Co. Kg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Embl Technology Fund Ii Gmbh & Co. Kg is 0.28%. GuruFocus also compares Embl Technology Fund Ii Gmbh & Co. Kg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Embl Technology Fund Ii Gmbh & Co. Kg within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Embl Technology Fund Ii Gmbh & Co. Kg's insider trading performs compared to the benchmark.
Performance of Embl Technology Fund Ii Gmbh & Co. Kg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.97 | | | | | |
| Relative Return to S&P 500(%) | -17.73 | | | | | |
Embl Technology Fund Ii Gmbh & Co. Kg Ownership Network
Ownership Network List of Embl Technology Fund Ii Gmbh & Co. Kg
Ownership Network Relation of Embl Technology Fund Ii Gmbh & Co. Kg
Embl Technology Fund Ii Gmbh & Co. Kg Owned Company Details
What does X4 Pharmaceuticals Inc do?
Who are the key executives at X4 Pharmaceuticals Inc?
Embl Technology Fund Ii Gmbh & Co. Kg is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .
X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary
Over the past 18 months, Embl Technology Fund Ii Gmbh & Co. Kg made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 601,883 shares made by Paula Ragan , a net sale of 161,480 shares made by Mary Dibiase , and a net sale of 552,345 shares made by Adam S. Mostafa .
In summary, during the past 3 months, insiders sold 660,362 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 660,362 shares. During the past 18 months, 1,626,785 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,785 shares.
X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
X4 Pharmaceuticals Inc Insider Transactions
Embl Technology Fund Ii Gmbh & Co. Kg Mailing Address
Above is the net worth, insider trading, and ownership report for Embl Technology Fund Ii Gmbh & Co. Kg. You might contact Embl Technology Fund Ii Gmbh & Co. Kg via mailing address: Boxbergring 107, Heidelberg 2m 69126.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
